ARCHIVES

In Brief: NCI Funded To Dec. 15, No Senate Figure Yet; Speedup Urged On Interferon Manufacturing, Testing

This article is from The Cancer Letter archive.

Vol. 06 No. 40 | October 10, 1980

Download PDF Visit The Full Archive

Related Articles

Surveillance Treatment Option For Low-Risk Prostate Cancer

July 30, 2010

Proflavine Bioassay Ineffective, NCI Says

July 15, 1977

NCI Chips In $2 Million For AACR Meeting; Advisors, Senior Staff Not Consulted.

June 20, 2003

Competition Developing For Three New Regional Cooperative Group Awards; RFA Within Two Months

December 12, 1980

Defying critics, von Eschenbach describes hands-on role at NCI while running FDA. NCI is unified behind 2015 goal, he says.

December 9, 2005

NCI May Support More Training Of Cancer Surgeons

May 23, 1975